Association between health behaviours and the COVID-19 vaccination: risk compensation among healthcare workers in Taizhou, China

References

• Lin HJ, Guo CC, Hu YF, Liang HB, Shen WW, Mao WH, He N. COVID-19 control strategies in Taizhou city, China. Bull World Health Organ. 2020;98:632–7. doi:10.2471/BLT.20.255778.
   PubMed Web of Science ®Google Scholar
• Wang JH, Jing RZ, Lai XZ, Zhang HJ, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 2020;8:482. doi:10.3390/vaccines8030482.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, Ren LL, Zhao JP, Hu Y, Zhang L, Fan GH, Xu JY, Gu XY, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi:10.1016/j.virusres.2020.198043.
   PubMed Web of Science ®Google Scholar
• Wadman M, You J. The vaccine wars. Science. 2017;356:364–65. doi:10.1126/science.356.6336.364.
   PubMed Web of Science ®Google Scholar
• Zhang MX, Zhang TT, Shi GF, Cheng FM, Zheng YM, Tung TH, Chen HX. Safety of an inactivate SARS-COV-2 vaccine among healthcare workers in China. Expert Rev Vaccines. 2021;20:891–98. doi:10.1186/s13063-020-04775-4.Trials.
   PubMed Web of Science ®Google Scholar
• Wang Q, Xiu SX, Zhao SY, Wang JL, Han Y, Dong SH, Huang JX, Cui TT, Yang LQ, Shi NY, et al. Vaccine hesitancy: COVID-19 and influenza vaccine willingness among parents in Wuxi, China—a cross-sectional study. Vaccines. 2021;9:342. doi:10.3390/vaccines9040342.
   PubMed Web of Science ®Google Scholar
• Ogoina D. Improving appropriate use of medical masks for COVID-19 prevention: the role of face mask containers. Am Soc Trop Med Hyg. 2020;103:965–66. doi:10.4269/ajtmh.20-0886.
   PubMed Web of Science ®Google Scholar
• Tabary M, Araghi F, Nasiri S, Dadkhahfar S. Dealing with skin reactions to gloves during the COVID-19 pandemic. Infect Control Hosp Epidemiol. 2020;42(2):247–48. doi:10.1017/ice.2020.212.
   PubMed Web of Science ®Google Scholar
• Przekwas A, Chen ZJ. Washing hands and the face may reduce COVID-19 infection. Med Hypotheses. 2020;144:110261. doi:10.1016/j.mehy.2020.110261.
   PubMed Web of Science ®Google Scholar
• Adams J, Hillman M. The risk compensation theory and bicycle helmets. Inj Prev. 2001;7:89–90. discussion 90. doi:10.1136/ip.7.4.343.
   PubMedGoogle Scholar
• Young AM, Halgin DS, DiClemente RJ, Sterk CE, Havens JR. Will HIV vaccination reshape HIV risk behavior networks? A social network analysis of drug users’ anticipated risk compensation. PLoS One. 2014;9(101047):e101047. doi:10.1371/journal.pone.0101047.
   PubMed Web of Science ®Google Scholar
• Newman PA, Lee SJ, Duan NH, Rudy E, Nakazona TK, Boscardin J, Kakinami L, Shoptaw S, Diamant A, Cunningham WE. Preventive HIV vaccine acceptability and behavioral risk Compensation among a random sample of high-RiskAdults in Los Angeles (LA VOICES). Health Serv Res. 2009;44:2167–79. doi:10.1111/j.1475-6773.2009.01039.x.
   PubMed Web of Science ®Google Scholar
• Marlow LA, Forster AS, Wardle J, Waller J. Mothers’ and adolescents’ beliefs about risk compensation following HPV vaccination. J Adolesc Health. 2009;44:446–51. doi:10.1016/j.jadohealth.2008.09.011.
   PubMed Web of Science ®Google Scholar
• Trogen B, Caplan A. Risk compensation and COVID-19 vaccines. Ann Intern Med. 2021;174:858–59. PMID:33646837. doi:10.7326/M20-8251.
   PubMed Web of Science ®Google Scholar
• Mantzari E, Rubin GJ, Marteau TM. Is risk compensation threatening public health in the covid-19 pandemic? BMJ. 2020;370:m2913. doi:10.1136/bmj.m2913.
   PubMed Web of Science ®Google Scholar
• Newman PA, Roungprakhon S, Tepjan S, Yim S. Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand. Vaccine. 2010;28:958–64. doi:10.1016/j.vaccine.2009.10.142.
   PubMed Web of Science ®Google Scholar
• Hansen BT. No evidence that HPV vaccination leads to sexual risk compensation. Hum Vaccin Immunother. 2016;12:1451–53. doi:10.1080/21645515.2016.1158367.
   PubMed Web of Science ®Google Scholar
• Frio GS, França MTA. Human papillomavirus vaccine and risky sexual behavior: regression discontinuity design evidence from Brazil. Econ Hum Biol. 2021;40:100946. doi:10.1016/j.ehb.2020.100946.
   PubMed Web of Science ®Google Scholar
• Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med. 2012;42:44–52. doi:10.1016/j.amepre.2011.09.024.
   PubMed Web of Science ®Google Scholar
• Wu T, Qu SY, Fang Y, Ip M, Wang ZX. Behavioral intention to performrisk compensation behaviors after receiving HPVvaccination among men who have sex with men inChina. Human Vaccine Immunother. 2019;15:1737–44. doi:10.1080/21645515.2019.1622975.
   PubMed Web of Science ®Google Scholar
• Painter JE, DiClemente RJ, Jimenez L, Stuart T, Sales JM, Mulligan MJ. Exploring evidence for behavioral risk compensation among participants in an HIV vaccine clinical trial. Vaccine. 2017;35:3558–63. doi:10.1016/j.vaccine.2017.05.024.
   PubMed Web of Science ®Google Scholar
• Brewer NT, Cuite CL, Herrington JE, Weinstein ND. Risk compensation and vaccination: can getting vaccinated cause People to engage in risky behaviors? Ann Behav Med. 2007;34:95–99. doi:10.1007/BF02879925.
   PubMed Web of Science ®Google Scholar
• Painter JE, Temple BS, Woods LA, Cwiak C, Haddad LB, Mulligan MJ, DiClemente RJ. Theory-based analysis of interest in anHIV vaccine for reasons indicative of risk compensation among African American women. Health Educ Behav. 2018;45:444–53. doi:10.1177/1090198117736860.
   PubMed Web of Science ®Google Scholar
• Leidner AJ, Chesson HW, Talih M. HPV vaccine status and sexual behavior among young sexually-active women in the US: evidence from the National Health and Nutrition Examination Survey, 2007–2014. Health Econ Policy Law. 2020;15:477–95. doi:10.1017/S1744133119000136.
   PubMed Web of Science ®Google Scholar